<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03945942</url>
  </required_header>
  <id_info>
    <org_study_id>2018/07NOV/413</org_study_id>
    <nct_id>NCT03945942</nct_id>
  </id_info>
  <brief_title>Influence of Hyperbilirubinaemia on Two Different Near Infrared Spectroscopy Devices</brief_title>
  <acronym>NIRS_GREFFE</acronym>
  <official_title>Influence of Hyperbilirubinaemia on Foresight and INVOS Oximetry Values in Pediatric Hepatic Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Protocol Near infrared spectroscopy liver transplants: comparison of two monitoring of Near
      infrared spectroscopy in pediatric liver transplant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyperbilirubinaemia may interfere with oximetry values as measured by Near Infrared
      Spectroscopy devices. The number of wave lengths used by different devices can influence the
      oximetry values in adult patients. This has never been demonstrated in children with
      hyperbilirubinaemia scheduled for elective liver transplantation.The study will compare
      cerebral and somatic oximetry values measured by two different Near infrared spectroscopy
      devices (FORESIGHT and INVOS) and analyse the influence of bilirubin levels on these
      differences.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2019</start_date>
  <completion_date type="Anticipated">April 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>influence of chromophores such as bilirubin on oximetry values provided by two different devices</measure>
    <time_frame>From Day 0 of surgery until arrival at pediatric intensive care unit (up to 12 hours)</time_frame>
    <description>measure of oximetry values by two different devices at different time points in function of serum bilirubin levels</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Liver Transplant; Complications</condition>
  <arm_group>
    <arm_group_label>Pediatric liver transplant patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Using somatic and cerebral Near infrared spectroscopy devices</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Near infrared spectroscopy with INVOS device</intervention_name>
    <description>somatic and cerebral oximetry by INVOS in pediatric liver transplantation</description>
    <arm_group_label>Pediatric liver transplant patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Near infrared spectroscopy with Foresight device</intervention_name>
    <description>somatic and cerebral oximetry with Foresight device in pediatric liver transplantation</description>
    <arm_group_label>Pediatric liver transplant patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric patients 0 to 18 years, with a liver transplant with living donor program of
             our institution

          -  Free, informed and written consent signed by the investigator or employees and by the
             legal guardians of minor patients in the days preceding the procedure

        Exclusion Criteria:

          -  refusal of the patient or his parents to consent

          -  known brain or Neurological pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Natalia MAGASICH-AIROLA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>natalia.magasich@uclouvain.be</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MAGASICH-AIROLA Natalia, MD</last_name>
    <phone>+3227648034</phone>
    <email>natalia.magasich@uclouvain.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia MAGASICH-AIROLA, MD</last_name>
      <phone>+3227648034</phone>
      <email>natalia.magasich@uclouvain.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2019</study_first_posted>
  <last_update_submitted>May 8, 2019</last_update_submitted>
  <last_update_submitted_qc>May 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperbilirubinemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

